THRD Third Harmonic Bio Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: THRD

Price (delayed)

$11.065

Market cap

$450.5M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.78

Enterprise value

$184.93M

Highlights
The company's EPS has surged by 68% YoY
The company's net income rose by 13% QoQ and by 12% YoY
THRD's quick ratio is up by 7% since the previous quarter but it is down by 2.8% year-on-year
The equity fell by 7% YoY
Sector: Healthcare
Industry: Biotechnology
Peers: NVCR NVAX

Key stats

What are the main financial stats of THRD
Market
Shares outstanding
40.71M
Market cap
$450.5M
Enterprise value
$184.93M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.66
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$30.82M
EBITDA
-$30.23M
Free cash flow
-$20.59M
Per share
EPS
-$0.78
Free cash flow per share
-$0.52
Book value per share
$6.67
Revenue per share
$0
TBVPS
$7
Balance sheet
Total assets
$277.71M
Total liabilities
$8.63M
Debt
$3.95M
Equity
$269.09M
Working capital
$267.03M
Liquidity
Debt to equity
0.01
Current ratio
50.29
Quick ratio
49.75
Net debt/EBITDA
8.79
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-10.8%
Return on equity
-11.2%
Return on invested capital
-433.8%
Return on capital employed
-11.3%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

THRD stock price

How has the Third Harmonic Bio stock price performed over time
Intraday
2.17%
1 week
-5.02%
1 month
17.21%
1 year
144.26%
YTD
0.87%
QTD
17.21%

Financial performance

How have Third Harmonic Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$43.95M
Net income
-$30.82M
Gross margin
N/A
Net margin
N/A
THRD's operating income is down by 17% year-on-year but it is up by 7% since the previous quarter
The company's net income rose by 13% QoQ and by 12% YoY

Growth

What is Third Harmonic Bio's growth rate over time

Valuation

What is Third Harmonic Bio stock price valuation
P/E
N/A
P/B
1.66
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 68% YoY
The stock's price to book (P/B) is 62% more than its last 4 quarters average of 1.0
The equity fell by 7% YoY

Efficiency

How efficient is Third Harmonic Bio business performance
THRD's ROIC has soared by 80% YoY and by 9% from the previous quarter
The return on equity has surged by 61% year-on-year and by 11% since the previous quarter
THRD's return on assets is up by 34% year-on-year and by 12% since the previous quarter

Dividends

What is THRD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for THRD.

Financial health

How did Third Harmonic Bio financials performed over time
The total liabilities has contracted by 10% YoY and by 7% from the previous quarter
Third Harmonic Bio's total assets has decreased by 7% YoY
Third Harmonic Bio's debt is 99% lower than its equity
The company's debt to equity has shrunk by 50% QoQ and by 50% YoY
Third Harmonic Bio's debt has decreased by 9% YoY and by 4.1% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.